Michael Steel Selected Research

darifenacin

7/2008	Clinical relevance of health-related quality of life outcomes with darifenacin.
11/2007	Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study.
11/2006	Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Steel Research Topics

Disease

3	Overactive Urinary Bladder (Overactive Bladder) 07/2008 - 11/2006
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2008
2	Breast Neoplasms (Breast Cancer) 07/2009 - 01/2008
1	Cysts 09/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2009
1	Ovarian Neoplasms (Ovarian Cancer) 07/2009
1	Neoplasms (Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

3	darifenacin FDA Link 07/2008 - 11/2006
1	Inhibins (Inhibin)IBA 09/2019
1	Biological ProductsIBA 01/2019
1	NucleotidesIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Hormones (Hormone)IBA 07/2009
1	Oral ContraceptivesIBA 07/2009
1	Pharmaceutical PreparationsIBA 01/2008
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	Cholinergic Agents (Cholinergics)IBA 11/2007

Therapy/Procedure

1	Therapeutics 01/2008
1	Chemoprevention 01/2008